TA
PTCT icon

Teachers Advisors’s PTC Therapeutics PTCT Stock Holding History

Teachers Advisors’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$11.4M Buy
302,917
+9,202
+3% +$309K 0.01% 934
2018
Q4 		$10.1M Sell
293,715
-184,090
-39% -$6.62M 0.01% 926
2018
Q3 		$22.5M Buy
477,805
+71,215
+18% +$2.95M 0.03% 668
2018
Q2 		$13.7M Buy
406,590
+31,368
+8% +$978K 0.02% 935
2018
Q1 		$10.2M Buy
375,222
+300,593
+403% +$7.62M 0.01% 1022
2017
Q4 		$1.25M Buy
74,629
+11,311
+18% +$191K ﹤0.01% 2124
2017
Q3 		$1.27M Buy
63,318
+1,994
+3% +$39K ﹤0.01% 2102
2017
Q2 		$1.12M Buy
61,324
+3,026
+5% +$40.8K ﹤0.01% 2164
2017
Q1 		$574K Sell
58,298
-217,073
-79% -$2.63M ﹤0.01% 2471
2016
Q4 		$3M Buy
275,371
+223,033
+426% +$2.34M ﹤0.01% 1552
2016
Q3 		$733K Hold
52,338
– – ﹤0.01% 2262
2016
Q2 		$367K Buy
52,338
+2,434
+5% +$17.9K ﹤0.01% 2589
2016
Q1 		$321K Hold
49,904
– – ﹤0.01% 2577
2015
Q4 		$1.62M Buy
49,904
+731
+1% +$21.5K ﹤0.01% 1718
2015
Q3 		$1.31M Sell
49,173
-100
-0.2% -$4.28K ﹤0.01% 1829
2015
Q2 		$2.37M Buy
49,273
+11,872
+32% +$693K ﹤0.01% 1568
2015
Q1 		$2.28M Buy
37,401
+3,238
+9% +$198K ﹤0.01% 1573
2014
Q4 		$1.77M Sell
34,163
-15,861
-32% -$698K ﹤0.01% 1708
2014
Q3 		$2.2M Buy
50,024
+18,746
+60% +$586K ﹤0.01% 1532
2014
Q2 		$818K Buy
31,278
+14,628
+88% +$313K ﹤0.01% 2155
2014
Q1 		$435K Buy
16,650
+7,700
+86% +$207K ﹤0.01% 2474
2013
Q4 		$152K Hold
8,950
– – ﹤0.01% 2951
2013
Q3 		$192K Buy
+8,950
New +$156K ﹤0.01% 2840

Other funds holding PTCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Teachers Advisors's PTCT Position: Q1 2019 in Review

Teachers Advisors increased its PTC Therapeutics (PTCT) stake by 3.1% in Q1 2019, buying an estimated $309K and bringing the position to 302,917 shares worth $11.4M. The position accounts for 0.01% of the portfolio, ranked #934.

Teachers Advisors first reported a position in PTCT in Q3 2013 and has held it in 23 quarters since. The position peaked at $22.5M in Q3 2018. 174 funds tracked by Wall St. Rank hold PTCT as of Q1 2019.

  • Teachers Advisors held 302,917 shares of PTC Therapeutics worth $11.4M as of Q1 2019.
  • Teachers Advisors bought 9,202 PTC Therapeutics shares in Q1 2019, an estimated $309K.
  • PTC Therapeutics made up 0.01% of Teachers Advisors's portfolio in Q1 2019, its #934 holding.
  • Teachers Advisors first reported a position in PTC Therapeutics in Q3 2013 and has held it in 23 quarters since.
  • Teachers Advisors's PTC Therapeutics position peaked at $22.5M in Q3 2018.
  • 174 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.